149 related articles for article (PubMed ID: 25664505)
21. Liver toxicity is rare in rheumatoid arthritis patients using combination therapy with leflunomide and methotrexate.
Alves JA; Fialho SC; Morato EF; Castro GR; Zimmermann AF; Ribeiro GG; Neves FS; Pereira IA
Rev Bras Reumatol; 2011; 51(2):141-4. PubMed ID: 21584420
[TBL] [Abstract][Full Text] [Related]
22. The SMILE study -- safety of methotrexate in combination with leflunomide in rheumatoid arthritis.
Bird P; Griffiths H; Tymms K; Nicholls D; Roberts L; Arnold M; Burnet S; de Jager J; Scott J; Zochling J; Littlejohn G
J Rheumatol; 2013 Mar; 40(3):228-35. PubMed ID: 23322457
[TBL] [Abstract][Full Text] [Related]
23. [Acute interstitial pneumonia in patient with rheumatoid arthritis treated with leflunomide].
Siemion-Szcześniak I; Bartoszuk I; Bartosiewicz M; Jakubowska L; Wesołowski S; Kuś J
Pneumonol Alergol Pol; 2014; 82(6):568-75. PubMed ID: 25339568
[TBL] [Abstract][Full Text] [Related]
24. Adverse events with disease modifying antirheumatic drugs (DMARD): a cohort study of leflunomide compared with other DMARD.
Cannon GW; Holden WL; Juhaeri J; Dai W; Scarazzini L; Stang P
J Rheumatol; 2004 Oct; 31(10):1906-11. PubMed ID: 15468352
[TBL] [Abstract][Full Text] [Related]
25. Recurrent pneumothorax associated with pulmonary nodules after leflunomide therapy in rheumatoid arthritis: a case report and review of the literature.
Kim SH; Yoo WH
Rheumatol Int; 2011 Jul; 31(7):919-22. PubMed ID: 19862529
[TBL] [Abstract][Full Text] [Related]
26. Combination leflunomide and methotrexate (MTX) therapy for patients with active rheumatoid arthritis failing MTX monotherapy: open-label extension of a randomized, double-blind, placebo controlled trial.
Kremer J; Genovese M; Cannon GW; Caldwell J; Cush J; Furst DE; Luggen M; Keystone E; Bathon J; Kavanaugh A; Ruderman E; Coleman P; Curtis D; Kopp E; Kantor S; Weisman M; Waltuck J; Lindsley HB; Markenson J; Crawford B; Fernando I; Simpson K; Strand V
J Rheumatol; 2004 Aug; 31(8):1521-31. PubMed ID: 15290730
[TBL] [Abstract][Full Text] [Related]
27. The effect of gene polymorphisms on patient responses to rheumatoid arthritis therapy.
Tarnowski M; Paradowska-Gorycka A; Dąbrowska-Zamojcin E; Czerewaty M; Słuczanowska-Głąbowska S; Pawlik A
Expert Opin Drug Metab Toxicol; 2016; 12(1):41-55. PubMed ID: 26609565
[TBL] [Abstract][Full Text] [Related]
28. Cost effectiveness of adding leflunomide to a 5-year strategy of conventional disease-modifying antirheumatic drugs in patients with rheumatoid arthritis.
Maetzel A; Strand V; Tugwell P; Wells G; Bombardier C
Arthritis Rheum; 2002 Dec; 47(6):655-61. PubMed ID: 12522841
[TBL] [Abstract][Full Text] [Related]
29. Toward a definition and method of assessment of treatment failure and treatment effectiveness: the case of leflunomide versus methotrexate.
Wolfe F; Michaud K; Stephenson B; Doyle J
J Rheumatol; 2003 Aug; 30(8):1725-32. PubMed ID: 12913927
[TBL] [Abstract][Full Text] [Related]
30. Update 2011: leflunomide in rheumatoid arthritis - strengths and weaknesses.
Behrens F; Koehm M; Burkhardt H
Curr Opin Rheumatol; 2011 May; 23(3):282-7. PubMed ID: 21427581
[TBL] [Abstract][Full Text] [Related]
31. Treatment with leflunomide slows radiographic progression of rheumatoid arthritis: results from three randomized controlled trials of leflunomide in patients with active rheumatoid arthritis. Leflunomide Rheumatoid Arthritis Investigators Group.
Sharp JT; Strand V; Leung H; Hurley F; Loew-Friedrich I
Arthritis Rheum; 2000 Mar; 43(3):495-505. PubMed ID: 10728741
[TBL] [Abstract][Full Text] [Related]
32. The -174G/C Interleukin-6 Gene Promoter Polymorphism as a Genetic Marker of Differences in Therapeutic Response to Methotrexate and Leflunomide in Rheumatoid Arthritis.
Ruiz-Padilla AJ; Gamez-Nava JI; Saldaña-Cruz AM; Murillo-Vazquez JD; Vazquez-Villegas ML; Zavaleta-Muñiz SA; Martín-Márquez BT; Ponce-Guarneros JM; Rodriguez Jimenez NA; Flores-Chavez A; Sandoval-Garcia F; Vasquez-Jimenez JC; Cardona-Muñoz EG; Totsuka-Sutto SE; Gonzalez-Lopez L
Biomed Res Int; 2016; 2016():4193538. PubMed ID: 27738630
[No Abstract] [Full Text] [Related]
33. The role of Chinese herbal medicine in the management of adverse drug reactions of leflunomide in treating rheumatoid arthritis.
Wang W; Zhou H; Liu L
Phytomedicine; 2020 Mar; 68():153136. PubMed ID: 32062477
[TBL] [Abstract][Full Text] [Related]
34. Pharmacogenetics and pharmacogenomics in rheumatology.
Szekanecz Z; Meskó B; Poliska S; Váncsa A; Szamosi S; Végh E; Simkovics E; Laki J; Kurkó J; Besenyei T; Mikecz K; Glant TT; Nagy L
Immunol Res; 2013 Jul; 56(2-3):325-33. PubMed ID: 23564183
[TBL] [Abstract][Full Text] [Related]
35. Leflunomide-induced interstitial lung disease: prevalence and risk factors in Japanese patients with rheumatoid arthritis.
Sawada T; Inokuma S; Sato T; Otsuka T; Saeki Y; Takeuchi T; Matsuda T; Takemura T; Sagawa A;
Rheumatology (Oxford); 2009 Sep; 48(9):1069-72. PubMed ID: 19321513
[TBL] [Abstract][Full Text] [Related]
36. [Leflunomide--a new disease modifying anti-rheumatic agent].
Rødevand E; Kvien TK; Johnsen V
Tidsskr Nor Laegeforen; 2001 Nov; 121(27):3181-4. PubMed ID: 11876141
[TBL] [Abstract][Full Text] [Related]
37. Combination of cyclosporine and leflunomide versus single therapy in severe rheumatoid arthritis.
Karanikolas G; Charalambopoulos D; Andrianakos A; Antoniades C; Katsilambros N
J Rheumatol; 2006 Mar; 33(3):486-9. PubMed ID: 16511917
[TBL] [Abstract][Full Text] [Related]
38. [Leflunomide in the treatment of rheumatoid arthritis].
Kochbati S; Ben Miled M; Boussema F; Ktari S; Daoud L; Ben Rhouma S; Ben Amor G; Chérif O; Rokbani L
Tunis Med; 2005 Feb; 83(2):91-7. PubMed ID: 15969231
[TBL] [Abstract][Full Text] [Related]
39. Chitosan coated clove oil-based nanoemulsion: An attractive option for oral delivery of leflunomide in rheumatoid arthritis.
Zewail MB; El-Gizawy SA; Asaad GF; Shabana ME; El-Dakroury WA
Int J Pharm; 2023 Aug; 643():123224. PubMed ID: 37451327
[TBL] [Abstract][Full Text] [Related]
40. Pharmacogenetics of disease-modifying anti-rheumatic drugs.
Tanaka E; Taniguchi A; Urano W; Yamanaka H; Kamatani N
Best Pract Res Clin Rheumatol; 2004 Apr; 18(2):233-47. PubMed ID: 15121042
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
